Health Catalyst (HCAT) | Stock Overview & Key Data
Health Catalyst Performance Comparison
Stock Range
Today's Range
Low: $3.29
High: $3.66
on August 29, 2025
52 Week Range
Low: $2.52
High: $9.24
on August 11, 2025
on December 2, 2024
All-Time High: $59.50 on June 7, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$260.7M
EPS
-1.51
P/E Ratio (TTM)
-3.17
Forward P/E
8.82
P/B Ratio
0.75
PEG Ratio
-0.02
Div. Yield
N/A
ROE
-28.42%
Beta
1.464
Debt to Equity
49.72
Financial Highlights
Profitability
Gross Margin
47.37%
Operating Margin
-14.45%
Profit Margin
-31.67%
Returns and Earnings
Return on Assets (TTM)
-4.99%
Return on Equity (TTM)
-28.42%
EBITDA
$-17.9M
Net Income (TTM)
$-100.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$4.94
Quarterly Revenue Growth (YoY)
6.30%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Health Catalyst HCAT | 260.73M Small-cap | 3.35% | -13.52% | -9.36% | -27.41% | -53.81% | -52.85% | -70.47% | -89.45% |
| Veeva Systems VEEV | 44.50B Large-cap | -7.45% | -6.28% | -3.53% | 20.10% | 27.84% | 24.38% | 58.38% | -0.14% |
| Ge Healthcare GEHC | 33.90B Large-cap | -1.98% | -5.13% | 3.08% | -15.59% | -5.93% | -13.07% | 29.94% | 29.94% |
| Certara CERT | 1.76B Small-cap | -5.49% | 1.88% | -4.91% | -9.52% | 1.69% | -11.51% | -28.21% | -71.53% |
| 10x Genomics TXG | 1.76B Small-cap | -2.03% | 0.07% | 50.00% | 31.06% | -1.27% | -40.00% | -54.45% | -86.82% |
| GoodRx Holdings GDRX | 1.56B Small-cap | -4.61% | -10.68% | 14.17% | -12.65% | -4.61% | -44.94% | -24.61% | -91.64% |
Ownership & Short Interest
Insider Ownership
3.45%
Institutional Ownership
79.75%
Shares Short
5M
Short Ratio
6.23
Short % of Shares Outstanding
7.94%
Average 10-Day Volume
867K
Average 90-Day Volume
827K
Health Catalyst Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Health Catalyst would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is HCAT's 52-week high and low?
- In the last 52 weeks, Health Catalyst reached a high of $9.24 (on December 2, 2024) and a low of $2.52 (on August 11, 2025).
- What is the market cap and P/E ratio for HCAT?
- Curious about Health Catalyst's size and valuation? Its market capitalization stands at 260.73M. When it comes to valuation, the P/E ratio (trailing twelve months) is -3.17, and the forward P/E (looking ahead) is 8.82.
- Does HCAT pay dividends? If so, what's the yield?
- As for dividends, Health Catalyst isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Health Catalyst's main competitors or similar companies to consider before investing?
When looking at Health Catalyst, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Veeva Systems
VEEV44.50B Healthcare Health Information Services 24.38% 58.38% Ge Healthcare
GEHC33.90B Healthcare Health Information Services -13.07% 29.94% Certara
CERT1.76B Healthcare Health Information Services -11.51% -28.21% 10x Genomics
TXG1.76B Healthcare Health Information Services -40.00% -54.45% GoodRx Holdings
GDRX1.56B Healthcare Health Information Services -44.94% -24.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Health Catalyst Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Health Catalyst's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -28.42%, the Debt to Equity ratio from the most recent quarter is 49.72, and its Gross Profit Margin stands at 47.37%.
- What is the recent revenue and earnings growth for HCAT?
- Looking at Health Catalyst's growth, its revenue over the trailing twelve months (TTM) was $316M. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.30%, and quarterly earnings saw a YoY growth of N/A.
- How much of HCAT stock is held by insiders and institutions?
- Wondering who owns Health Catalyst stock? Company insiders (like executives and directors) hold about 3.45% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 79.75%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.